Alaska Energy Metals - Logo - Gradient - Final-01-Web (1).png
Alaska Energy Metals Announces Automatic Conversion of Special Warrants
September 18, 2024 17:01 ET | Alaska Energy Metals Corporation
PROSPECTUS SUPPLEMENT AND BASE SHELF PROSPECTUS ACCESSIBLE ON SEDAR+ VANCOUVER, British Columbia, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Alaska Energy Metals Corporation (TSX-V: AEMC, OTCQB: AKEMF)...
FCPERT Logo.PNG
FC Private Equity Realty Management Corp. Responds to Melcor REIT “Take Under” Transaction:
September 18, 2024 17:01 ET | Firm Capital Private Equity Realty Trust
As Feared, Melcor Developments Ltd. is Fleecing Melcor REIT Unitholders!  Melcor Developments Ltd. Needs to be Honourable and Take Melcor REIT Private at NAV and Stop the Self Dealing That...
Picture1.jpg
InspireSemi Announces Final Closing of Private Placement
September 18, 2024 17:01 ET | Inspire Semiconductor Holdings Inc.
InspireSemi Announces Final Closing of Private Placement
iLearningEngines logo.jpg
iLearningEngines and GenLab Venture Studio Announce Strategic Alliance to fast-track Enterprise AI Applications Using Generative AI within Global Enterprises
September 18, 2024 17:00 ET | iLearningEngines Holdings, Inc.
BETHESDA, Md., Sept. 18, 2024 (GLOBE NEWSWIRE) -- iLearningEngines, Inc. (Nasdaq: AILE) (“iLearningEngines,” “ILE,” or “the Company”), a leader in AI-powered learning and work automation for...
fanhua_logo.jpg
Fanhua Reports First Half 2024 Unaudited Financial Results
September 18, 2024 17:00 ET | Fanhua Inc.
GUANGZHOU, China, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Fanhua Inc. (Nasdaq: FANH) (the “Company” or “Fanhua”), a leading independent financial services provider in China, today announced its unaudited...
Aligos.png
Aligos Therapeutics to Announce Topline Results from the Phase 2a HERALD Study of ALG-055009 for the Treatment of MASH on September 19, 2024
September 18, 2024 17:00 ET | Aligos Therapeutics
SOUTH SAN FRANCISCO, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient...
Cytek Logo - Color.jpg
Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe
September 18, 2024 17:00 ET | Cytek Biosciences, Inc.
Cytek to spotlight its Full Spectrum Profiling technology and advanced cell analysis solutions at ICCS and ESCCA.
ultragenyx-CMYK.png
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 18, 2024 17:00 ET | Ultragenyx Pharmaceutical Inc.
NOVATO, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, A LEADING LAW FIRM, Encourages Stellantis N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action – STLA
September 18, 2024 16:53 ET | The Rosen Law Firm PA
NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Stellantis N.V. (NYSE: STLA) between February 15, 2024 and...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, A LEADING LAW FIRM, Encourages Sprinklr, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CXM
September 18, 2024 16:49 ET | The Rosen Law Firm PA
NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sprinklr, Inc. (NYSE: CXM) between March 29, 2023 and June...